Kanya Rajangam - 02 Feb 2026 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Role: Pres. & Chief Med. & Dev. Off.
Signature: /s/ Robert Cutler, attorney-in-fact
Issuer symbol: SNTI
Transactions as of: 02 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 03 Feb 2026, 16:17:23 UTC
Previous filing: 11 Mar 2025
Next filing: 11 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Rajangam Kanya	Pres. & Chief Med. & Dev. Off.	C/O SENTI BIOSCIENCES, INC., 2 CORPORATE DRIVE FIRST FLOOR, SOUTH SAN FRANCISCO	/s/ Robert Cutler, attorney-in-fact	03 Feb 2026	0001816676

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SNTI	Common Stock	Tax liability	$0	-1,384	-1.6%	$0.000000	85,600	02 Feb 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of certain time-based restricted stock unit awards and does not represent an open market sale.